loadpatents
name:-0.022413969039917
name:-0.024868965148926
name:-0.0014069080352783
Zamecnik; Paul C. Patent Filings

Zamecnik; Paul C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zamecnik; Paul C..The latest application filed is for "oligonucleotide complex compositions".

Company Profile
0.16.7
  • Zamecnik; Paul C. - Boston MA
  • Zamecnik, Paul C. - Shrewsbury MA
  • Zamecnik; Paul C. - Shrewbury MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Oligonucleotide complex compositions and methods of use as gene alteration tools
Grant 9,617,535 - Tabatadze , et al. April 11, 2
2017-04-11
Oligonucleotide Complex Compositions
App 20150284708 - Tabatadze; David R. ;   et al.
2015-10-08
Oligonucleotide complex compositions and methods of use as gene alteration tools
Grant 8,841,271 - Tabatadze , et al. September 23, 2
2014-09-23
Oligonucleotide complex compositions and methods of use as gene alteration tools
Grant 8,314,226 - Tabatadze , et al. November 20, 2
2012-11-20
Oligonucleotide Complex Compositions And Methods Of Use As Gene Alteration Tools
App 20120252880 - Tabatadze; David R. ;   et al.
2012-10-04
New Modalities For Treatment Of Drug-resistant Tuberculosis And Other Diseases
App 20100204310 - Zamecnik; Paul C. ;   et al.
2010-08-12
Oligonucleotide Complex Compositions and Methods of Use as Gene Alteration Tools
App 20080287379 - Tabatadze; David R. ;   et al.
2008-11-20
Treatment of mycobacterium tuberculosis with antisense polynucleotides
App 20040033972 - Horwitz, Marcus A. ;   et al.
2004-02-19
Inhibition of infectious agents by exogenous oligonucleotides
App 20030191078 - Goodchild, John ;   et al.
2003-10-09
Inhibition of infectious agents by exogenous oligonucleotides
App 20030186911 - Goodchild, John ;   et al.
2003-10-02
Oligonucleotides active against drug-resistant bacteria
Grant 6,335,436 - Rapaport , et al. January 1, 2
2002-01-01
Conjugates of minor groove DNA binders with antisense oligonucleotides
Grant 5,955,590 - Levina , et al. September 21, 1
1999-09-21
Influenza virus replication inhibiting oligonucleotide analogues and their pharmaceutical compositions
Grant 5,637,573 - Agrawal , et al. June 10, 1
1997-06-10
Method of site-specific alteration of RNA and production of encoded polypeptides
Grant 5,635,377 - Pederson , et al. June 3, 1
1997-06-03
Antiparasitic oligonucleotides active against drug resistant malaria
Grant 5,616,564 - Rapaport , et al. April 1, 1
1997-04-01
Method of site-specific alteration of RNA and production of encoded polypeptides
Grant 5,366,878 - Pederson , et al. November 22, 1
1994-11-22
Method of site-specific alteration of RNA and production of encoded polypeptides
Grant 5,220,007 - Pederson , et al. June 15, 1
1993-06-15
Inhibition of influenza virus replication by oligonucleotide phosphorothioates
Grant 5,194,428 - Agrawal , et al. March 16, 1
1993-03-16
Process for synthesizing oligonucleotides and their analogs adaptable to large scale syntheses
Grant 5,149,798 - Agrawal , et al. September 22, 1
1992-09-22
Method of site-specific alteration of RNA and production of encoded polypeptides
Grant 5,149,797 - Pederson , et al. September 22, 1
1992-09-22
Diadenosine 5', 5'"-p.sup.1, p.sup.4,-tetraphosphate analogs as antithrombotic agents
Grant 5,049,550 - Zamecnik September 17, 1
1991-09-17
Inhibition of HTLV-III by exogenous oligonucleotides
Grant 4,806,463 - Goodchild , et al. February 21, 1
1989-02-21
Company Registrations
SEC0001195564ZAMECNIK PAUL C

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed